ArrePath Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3.7M

  • Investors
  • 10

ArrePath General Information

Description

Developer of an AI-driven oral small-molecule drug discovery platform, designed to rapidly identify and optimize novel chemical compounds across therapeutic areas with limited oral treatment options. The company's platform deploys target-specific AI and machine learning workflows to evaluate over one million molecules per design cycle while simultaneously optimizing potency and oral bioavailability, enabling pharmaceutical partners and investors to accelerate the development of new drug classes at machine scale.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 303A College Road East
  • Princeton, NJ 08540
  • United States
+1 (609)
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • 303A College Road East
  • Princeton, NJ 08540
  • United States
+1 (609)

ArrePath Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ArrePath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 02-Apr-2025 $3.7M Completed Generating Revenue
4. Seed Round 26-Mar-2025 Completed Generating Revenue
3. Grant 19-Nov-2024 Completed Generating Revenue
2. Seed Round 01-Aug-2023 $20M Completed Generating Revenue
1. Seed Round 03-Mar-2022 $20M $20M Completed Generating Revenue
To view ArrePath’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ArrePath Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an AI-driven oral small-molecule drug discovery platform, designed to rapidly identify and optimize novel c
Drug Discovery
Princeton, NJ
16 As of 2026

San Mateo, CA
 

Monrovia, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ArrePath Competitors (3)

One of ArrePath’s 3 competitors is Genesis Molecular AI, a Venture Capital-Backed company based in San Mateo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genesis Molecular AI Venture Capital-Backed San Mateo, CA
Terray Therapeutics Venture Capital-Backed Monrovia, CA
Seismic Therapeutic Venture Capital-Backed Watertown, MA
You’re viewing 3 of 3 competitors. Get the full list »

ArrePath Patents

ArrePath Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026039664-A1 Systems and methods for ranking molecules Pending 16-Aug-2024
WO-2025231269-A1 Antibacterial compounds Pending 02-May-2024
WO-2025231273-A1 Antibacterial compounds Pending 02-May-2024
EP-4795034-A1 Antibacterial compounds Pending 20-Oct-2023
WO-2025085848-A1 Antibacterial compounds Inactive 20-Oct-2023 C07D277/42
To view ArrePath’s complete patent history, request access »

ArrePath Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ArrePath Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
CARB-X University
PACE (UK) Government
Westfield BioVentures Accelerator/Incubator Minority
Arimed Advisors Venture Capital Minority
Boehringer Ingelheim Venture Fund Corporate Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

ArrePath FAQs

  • When was ArrePath founded?

    ArrePath was founded in 2021.

  • Where is ArrePath headquartered?

    ArrePath is headquartered in Princeton, NJ.

  • What is the size of ArrePath?

    ArrePath has 16 total employees.

  • What industry is ArrePath in?

    ArrePath’s primary industry is Drug Discovery.

  • Is ArrePath a private or public company?

    ArrePath is a Private company.

  • What is ArrePath’s current revenue?

    The current revenue for ArrePath is .

  • How much funding has ArrePath raised over time?

    ArrePath has raised $20M.

  • Who are ArrePath’s investors?

    CARB-X, PACE (UK), Westfield BioVentures, Arimed Advisors, and Boehringer Ingelheim Venture Fund are 5 of 10 investors who have invested in ArrePath.

  • Who are ArrePath’s competitors?

    Genesis Molecular AI, Terray Therapeutics, and Seismic Therapeutic are competitors of ArrePath.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process